Minerco (MINE) to Begin Distribution of its Medical Mushrooms, CBD and Delta 8 Product Lines Following Launch of Flagship Facility in Ann Arbor, Michigan

128
Google Ads

Miami, FL – April 7, 2021 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Minerco, Inc. (OTC PINK:MINE)

KINGSTON, JAMAICA / ACCESSWIRE / April 7, 2021 / Minerco, Inc. (“Minerco” or the “Company”) (OTC PINK:MINE) today announced that it expects to be the first Company in the Magic Mushroom industry to open an entire facility dedicated towards the distribution of its micro dosing product lines in addition to the CBD and Delta 8 products, amongst others, that will also be distributed by WLLCO, a white label CBD company that the Company acquired last month.

The Company initially announced on March 29, 2021 it had finalized a lease that will enable them to clearly solidify its position as the first mover in the nation’s rapidly emerging and highly lucrative Magic Mushroom industry.

Ann Arbor, Michigan Decriminalizes Psychedelics, Including Magic Mushrooms

The city of Ann Arbor, Michigan was one of the first cities across the nation that recently decriminalized psychedelic plants, paving the way for innovative companies like Minerco to quickly build a brand name for its product lines as it prepares for a nationwide rollout strategy, in conjunction with the decriminalization of additional cities across the nation,” said Julius Jenge, Chairman and CEO of Minerco, Inc. “Ann Arbor’s resolution defines entheogenic plants as plants and fungi that contain indole amines, tryptamines and phenethylamines ‘that can benefit psychological and physical wellness, support and enhance religious and spiritual practices, and can reestablish human’s inalienable and direct relationship to nature.’ We are firm believers in the healing powers that psychedelic plants can have on patients that are continuing to suffer from traditional Western medicine and are eagerly looking forward to introducing Minerco’s treatment for a wide variety of ailments, from depression to insomnia,” concluded Mr. Jenge.

About Minerco, Inc. (OTC:MINE)

Minerco, Inc. (OTC: MINE), which was acquired by psilocybin research and investment firm based out of Jamaica, is emerging as the world’s first publicly traded company focused on the research, production and distribution of psilocybin mushrooms.

Google Ads

Minerco, Inc. Forward-Looking Statements

This press release contains statements the Company believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. When used in this press release, words such as we “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “should”, or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information:

Minerco, Inc.
Investor Relations
Phone: 323-380-4500

SOURCE: Minerco, Inc.

About EmergingGrowth.com

Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows and virtual conferences to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is not the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  EmergingGrowth.com, or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, EmergingGrowth.com/Disclosure. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.